NK1-RECEPTORS MEDIATE THE PROLIFERATIVE RESPONSE OF HUMAN FIBROBLASTS TO TACHYKININS

被引:99
作者
ZICHE, M [1 ]
MORBIDELLI, L [1 ]
PACINI, M [1 ]
DOLARA, P [1 ]
MAGGI, CA [1 ]
机构
[1] A MENARINI PHARMACEUT, DEPT PHARMACOL, RES LABS, FLORENCE, ITALY
关键词
D O I
10.1111/j.1476-5381.1990.tb12043.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The effect of synthetic tachykinin selective receptor agonists was studied on the growth of cultured human skin fibroblasts (HF). 2. Human fibroblasts were grown in serum-free conditions in the presence of natural tachykinins (substance P and neurokinin A) and of three synthetic agonists, [β-Ala4, Sar9, Met(O2)11]-SP(4-11), [β-Ala8]-NKA(4-10) and [MePhe7]-NKB selective for NK1-, NK2- and NK3-receptors respectively. Cell proliferation was measured by percentage increase in cell number and by [3H]-thymidine uptake following 48 h exposure to agents compared to baseline condition. 3. Neurokinin A (NKA) and substance P (SP) significantly increased cell proliferation the threshold concentrations being 10-12 and 10-11 M, respectively. Addition of thiorphan to culture conditions enhanced the effect of SP but not of NKA. 4. The selective NK1-receptor agonist produced a dose-dependent increase in cell proliferation as judged by total cell number and [3H]-thymidine uptake. No significant effect was observed with NK2- and NK3-receptor agonists. 5. These data indicate that the effect of SP on fibroblast proliferation is mediated by interaction with a NK1-receptor type and local metabolism can interfere with the full expression of this effect of SP on cell proliferation.
引用
收藏
页码:11 / 14
页数:4
相关论文
共 27 条
[1]   ANTIDROMIC VASODILATATION AND NEUROGENIC INFLAMMATION [J].
CHAHL, LA .
PHARMACOLOGY & THERAPEUTICS, 1988, 37 (02) :275-300
[2]   COMPARISON OF THE EFFECTS OF EPITHELIUM REMOVAL AND OF AN ENKEPHALINASE INHIBITOR ON THE NEUROKININ-INDUCED CONTRACTIONS OF GUINEA-PIG ISOLATED TRACHEA [J].
DEVILLIER, P ;
ADVENIER, C ;
DRAPEAU, G ;
MARSAC, J ;
REGOLI, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (03) :675-684
[3]   CHARACTERIZATION OF NEUROKININ RECEPTORS IN VARIOUS ISOLATED ORGANS BY THE USE OF SELECTIVE AGONISTS [J].
DION, S ;
DORLEANSJUSTE, P ;
DRAPEAU, G ;
RHALEB, NE ;
ROUISSI, N ;
TOUSIGNANT, C ;
REGOLI, D .
LIFE SCIENCES, 1987, 41 (20) :2269-2278
[4]   SELECTIVE AGONISTS FOR SUBSTANCE-P AND NEUROKININ RECEPTORS [J].
DRAPEAU, G ;
DORLEANSJUSTE, P ;
DION, S ;
RHALEB, NE ;
ROUISSI, NE ;
REGOLI, D .
NEUROPEPTIDES, 1987, 10 (01) :43-54
[5]   NK-1 RECEPTORS MEDIATE THE TACHYKININ STIMULATION OF SALIVARY SECRETION - SELECTIVE AGONISTS PROVIDE FURTHER EVIDENCE [J].
GIULIANI, S ;
MAGGI, CA ;
REGOLI, D ;
DRAPEAU, G ;
ROVERO, P ;
MELI, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 150 (03) :377-379
[6]   EXPERIMENTAL IMMUNOHISTOCHEMICAL STUDIES ON LOCALIZATION AND DISTRIBUTION OF SUBSTANCE-P IN CAT PRIMARY SENSORY NEURONS [J].
HOKFELT, T ;
KELLERTH, JO ;
NILSSON, G ;
PERNOW, B .
BRAIN RESEARCH, 1975, 100 (02) :235-252
[8]   DECREASED SURVIVAL OF EXPERIMENTAL CRITICAL FLAPS IN RATS AFTER SENSORY DENERVATION WITH CAPSAICIN [J].
KJARTANSSON, J ;
DALSGAARD, CJ ;
JONSSON, CE .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1987, 79 (02) :218-221
[9]   MULTIPLE TACHYKININ BINDING-SITES IN PERIPHERAL-TISSUES AND IN BRAIN [J].
LEE, CM ;
CAMPBELL, NJ ;
WILLIAMS, BJ ;
IVERSEN, LL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 130 (03) :209-217
[10]  
LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282